2 completed. .
Follow Dose of Tinzaparin or Dalteparin: new trials by email Literature Review of Dose of Tinzaparin or Dalteparin trials Research Report on Dose of Tinzaparin or Dalteparin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anticoagulant Therapy and 28-days Mortality in Critically Ill COVID-19 Patients Dose of Tinzaparin or Dalteparin - Covid-19, Thromboembolic Events | Completed | Karolinska Institutet | 166 | 2020-03-06 | 2020-06-22 | |
| Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients Dose of tinzaparin or dalteparin - Covid19, Thromboembolism | Completed | Karolinska Institutet | 257 | 2020-03-01 | 2023-05-31 |
COVID-19 (2) · Hemorrhage (2) · Thromboembolism (2) · Ischemic Stroke (1) · Pulmonary Embolism (1)
Sweden (2)
Maria Cronhjort, PhD (1) · Sandra Jonmarker, MD (1)